Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
NUV-868 by Nuvation Bio for Triple-Negative Breast Cancer (TNBC): Likelihood of Approval
NUV-868 is under clinical development by Nuvation Bio and currently in Phase II for Triple-Negative Breast Cancer (TNBC). According to...
NUV-868 by Nuvation Bio for Peritoneal Cancer: Likelihood of Approval
NUV-868 is under clinical development by Nuvation Bio and currently in Phase II for Peritoneal Cancer. According to GlobalData, Phase...
NUV-868 by Nuvation Bio for Pancreatic Cancer: Likelihood of Approval
NUV-868 is under clinical development by Nuvation Bio and currently in Phase II for Pancreatic Cancer. According to GlobalData, Phase...
NUV-868 by Nuvation Bio for Ovarian Cancer: Likelihood of Approval
NUV-868 is under clinical development by Nuvation Bio and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase...